Benorilate

Revision as of 13:00, 13 April 2015 by Turky Alkathery (talk | contribs) (Created page with "{{Drugbox | Verifiedfields = changed | verifiedrevid = 461759359 | IUPAC_name = 4-(acetylamino)phenyl 2-(acetyloxy)benzoate | image = Benorilate.svg <!--Clinical data--> | tr...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Benorilate
File:Benorilate.svg
Clinical data
Routes of
administration
Oral
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC17H15NO5
Molar mass313.305 g/mol
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Benorilate (INN), or benorylate, is an ester-linked codrug of aspirin with paracetamol. It is used as an anti-inflammatory and antipyretic medication. In the treatment of childhood fever, it has been shown to be inferior to paracetamol and aspirin taken separately. In addition, because it is converted to aspirin, benorylate is not recommended in children due to concerns about Reye syndrome.[1]

References

  1. Simila S, Keinanen S, Kouvalainen K.Oral antipyretic therapy: evaluation of benorylate, an ester of acetylsalicylic acid and paracetamol. Eur J Pediatr. 1975 Dec 9;121(1):15-20. PMID 2478

Template:Salicylates


Template:Musculoskeletal-drug-stub Template:Analgesic-stub